As diabetes prevalence continues to increase, inpatient andout patient hyperglycemia becomes more common negatively affecting outcomes. During this session, the presenters will discuss the state of inpatient and outpatient insulin management, transition in care, how digital therapeutics have evolved, supporting research, and key factors to consider when moving from paper protocols to automated insulin dosing solutions.
This will be an oral presentation reviewing the impact of inpatient and outpatient hyperglycemia, hypoglycemia, and glycemic variability. Describing the differences between types of insulin and dosing algorithms. As well as reviewing the evidence on eGlycemic Management Systems (eGMS) and FDA cleared titration apps.
Review how eGMS and titration apps have evolved over time. Compare and contrast features, benefits and downsides of eGMS and titration apps.
Recognize how eGMS and titration apps can drive engagement and improve outcomes. Discuss needed future areas for research and outcome studies.